Wary Of Coronavirus Hype And Haste, Themis Looks To Future As Part Of Merck & Co.

Shared Culture Helped Seal Acquisition

 
• By Andrew McConaghie

Themis’ CEO on how Merck’s commitment to infectious diseases impressed him, and why regulators may not approve suboptimal COVID-19 vaccines.

Vienna_Conference_Center
Themis was established in Vienna in 2009

More from COVID-19

More from Scrip